NDC 13533-634

HyperTET S/D

Tetanus Immune Globulin (human)

HyperTET S/D is a Intramuscular Injection in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Human Clostridium Tetani Toxoid Immune Globulin.

Product ID13533-634_420af97e-f4a7-4405-8606-1abd96f33479
NDC13533-634
Product TypePlasma Derivative
Proprietary NameHyperTET S/D
Generic NameTetanus Immune Globulin (human)
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR
Marketing Start Date1996-08-14
Marketing CategoryBLA / BLA
Application NumberBLA101142
Labeler NameGRIFOLS USA, LLC
Substance NameHUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN
Active Ingredient Strength250 [iU]/mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 13533-634-02

1 SYRINGE, GLASS in 1 BOX (13533-634-02) > 1 mL in 1 SYRINGE, GLASS (13533-634-20)
Marketing Start Date1996-08-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13533-634-20 [13533063420]

HyperTET S/D INJECTION
Marketing CategoryBLA
Application NumberBLA101142
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2012-12-01

NDC 13533-634-02 [13533063402]

HyperTET S/D INJECTION
Marketing CategoryBLA
Application NumberBLA101142
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date1996-08-14

Drug Details

Active Ingredients

IngredientStrength
HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN250 [iU]/mL

Trademark Results [HyperTET]

Mark Image

Registration | Serial
Company
Trademark
Application Date
HYPERTET
HYPERTET
78622911 3202846 Live/Registered
GRIFOLS THERAPEUTICS LLC
2005-05-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.